These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 1336339)

  • 1. Daptomycin or teicoplanin in combination with gentamicin for treatment of experimental endocarditis due to a highly glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F; Kitzis MD; Gutmann L; Cremieux AC; Maziere B; Vallois JM; Saleh-Mghir A; Lemeland JF; Carbon C
    Antimicrob Agents Chemother; 1992 Dec; 36(12):2611-6. PubMed ID: 1336339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium.
    Fantin B; Leclercq R; Arthur M; Duval J; Carbon C
    Antimicrob Agents Chemother; 1991 Aug; 35(8):1570-5. PubMed ID: 1834013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of different beta-lactam-glycopeptide-gentamicin combinations for an experimental endocarditis caused by a highly beta-lactam-resistant and highly glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F; Pestel M; Kitzis MD; Lemeland JF; Humbert G; Gutmann L
    J Infect Dis; 1995 Jan; 171(1):106-12. PubMed ID: 7798650
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of daptomycin, vancomycin, and ampicillin-gentamicin for treatment of experimental endocarditis caused by penicillin-resistant enterococci.
    Ramos MC; Grayson ML; Eliopoulos GM; Bayer AS
    Antimicrob Agents Chemother; 1992 Sep; 36(9):1864-9. PubMed ID: 1329632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci.
    Leclercq R; Bingen E; Su QH; Lambert-Zechovski N; Courvalin P; Duval J
    Antimicrob Agents Chemother; 1991 Jan; 35(1):92-8. PubMed ID: 1849711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Comparative study of treatment with quinupristin-dalfopristin alone or in combination with gentamicin, teicoplanin, imipenem or levofloxacin in experimental endocarditis due to a multidrug-resistant Enterococcus faecium].
    Pérez Salmerón J; Martínez García F; Roldán Conesa D; Lorente Salinas I; López Fornás F; Ruiz Gómez J; Gómez Gómez J; Segovia Hernández M; Valdés Chávarri M
    Rev Esp Quimioter; 2006 Sep; 19(3):258-66. PubMed ID: 17099794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of teicoplanin-gentamicin given once a day on the basis of pharmacokinetics in humans for treatment of enterococcal experimental endocarditis.
    López P; Gavaldà J; Martin MT; Almirante B; Gomis X; Azuaje C; Borrell N; Pou L; Falcó V; Pigrau C; Pahissa A
    Antimicrob Agents Chemother; 2001 May; 45(5):1387-93. PubMed ID: 11302800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin.
    Yao JD; Thauvin-Eliopoulos C; Eliopoulos GM; Moellering RC
    Antimicrob Agents Chemother; 1990 May; 34(5):827-30. PubMed ID: 2141778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of daptomycin in the treatment of experimental endocarditis due to susceptible and multidrug-resistant enterococci.
    Vouillamoz J; Moreillon P; Giddey M; Entenza JM
    J Antimicrob Chemother; 2006 Dec; 58(6):1208-14. PubMed ID: 17030515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Triple-combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a moderately penicillin- and highly glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F; Carbon C; Gutmann L
    J Infect Dis; 1991 Nov; 164(5):888-93. PubMed ID: 1940467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple combination penicillin-vancomycin-gentamicin for experimental endocarditis caused by a highly penicillin-and glycopeptide-resistant isolate of Enterococcus faecium.
    Caron F; Lemeland JF; Humbert G; Klare I; Gutmann L
    J Infect Dis; 1993 Sep; 168(3):681-6. PubMed ID: 8354909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bactericidal activities of teicoplanin, vancomycin, and gentamicin alone and in combination against Staphylococcus aureus in an in vitro pharmacodynamic model of endocarditis.
    McGrath BJ; Kang SL; Kaatz GW; Rybak MJ
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2034-40. PubMed ID: 7811015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addition of gentamicin or rifampin does not enhance the effectiveness of daptomycin in treatment of experimental endocarditis due to methicillin-resistant Staphylococcus aureus.
    Miró JM; García-de-la-Mària C; Armero Y; Soy D; Moreno A; del Río A; Almela M; Sarasa M; Mestres CA; Gatell JM; Jiménez de Anta MT; Marco F;
    Antimicrob Agents Chemother; 2009 Oct; 53(10):4172-7. PubMed ID: 19620326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two-step acquisition of resistance to the teicoplanin-gentamicin combination by VanB-type Enterococcus faecalis in vitro and in experimental endocarditis.
    Lefort A; Baptista M; Fantin B; Depardieu F; Arthur M; Carbon C; Courvalin P
    Antimicrob Agents Chemother; 1999 Mar; 43(3):476-82. PubMed ID: 10049254
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Teicoplanin versus vancomycin for prophylaxis of experimental Enterococcus faecalis endocarditis in rats.
    Entenza JM; Calandra T; Moosmann Y; Malinverni R; Glauser MP
    Antimicrob Agents Chemother; 1992 Jun; 36(6):1256-62. PubMed ID: 1416824
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the novel combination of daptomycin plus ceftriaxone against vancomycin-resistant enterococci in an in vitro pharmacokinetic/pharmacodynamic simulated endocardial vegetation model.
    Hall Snyder A; Werth BJ; Barber KE; Sakoulas G; Rybak MJ
    J Antimicrob Chemother; 2014 Aug; 69(8):2148-54. PubMed ID: 24777900
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of in vitro inhibitory and bactericidal activities of daptomycin (LY 146032) and four reference antibiotics, singly and in combination, against gentamicin-susceptible and high-level-gentamicin-resistant enterococci.
    Louie A; Baltch AL; Ritz WJ; Smith RP; Asperilla M
    Chemotherapy; 1993; 39(5):302-9. PubMed ID: 8396526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo daptomycin efficacy against experimental vancomycin-resistant Enterococcus faecium endocarditis.
    Reissier S; Saleh-Mghir A; Guerin F; Massias L; Ghout I; Sinel C; Cattoir V; Cremieux AC
    J Antimicrob Chemother; 2018 Apr; 73(4):981-986. PubMed ID: 29329389
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daptomycin compared with teicoplanin and vancomycin for therapy of experimental Staphylococcus aureus endocarditis.
    Kaatz GW; Seo SM; Reddy VN; Bailey EM; Rybak MJ
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2081-5. PubMed ID: 1963526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergy of an investigational glycopeptide, LY333328, with once-daily gentamicin against vancomycin-resistant Enterococcus faecium in a multiple-dose, in vitro pharmacodynamic model.
    Zelenitsky SA; Booker B; Laing N; Karlowsky JA; Hoban DJ; Zhanel GG
    Antimicrob Agents Chemother; 1999 Mar; 43(3):592-7. PubMed ID: 10049272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.